The primary outcome will be the proportion of patients responding to treatment , defined in the depression trial as a PHQ-@ score < @ and an absolute reduction in PHQ-@ @ after @ months , and in the CVD risk trial as maintenance or reduction of @-year CVD risk after @ months .